ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2013

Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer.

G S Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.